Giving back to our community includes our 4-legged friends. Thank you to our team members and their families for donating time and resources to the Camarillo Animal Shelter. We’re proud to foster a #companyculture grounded in caring for all living beings. #ThisIsArcutUS

#NEWS: Today, we announced the appointment of Shawn Davis as Vice President of Market Access. Dr. Davis holds a Doctor of Pharmacy and brings with him 20+ years of relevant experience across multiple healthcare areas. Welcome to the team, Shawn! #ThisIsArcutUS

Today, we celebrate the birth of our nation and honor all who have defended our freedoms, past and present. Wishing everyone a safe and happy #IndependenceDay! #4thofJuly

#NEWS: We’re proud to announce the U.S. FDA approval of our once-daily cream for the treatment of adults and children ages 6+ with mild to moderate #atopicdermatitis. Learn more: bit.ly/4cVaQA8 #CompanyMilestone #FDAapproval

Head to the link below to learn about our recent milestone approval in #atopicdermatitis. bit.ly/4cVaQA8

We’re at the Society for PedsDerm Annual Meeting, where we’ll share data from studies evaluating our new once-daily treatment for adults and children age 6+ with #atopicdermatitis. Connect with us at our product theater to learn more. #ClinicalDermatology #PediatricDermatology

This week at the Society for PedsDerm Annual Meeting, we’ll present data from studies evaluating our new once-daily treatment for adults and children age 6+ with #atopicdermatitis. Learn more below. #ClinicalDermatology #PediatricDermatology

Join us next Monday, July 29 for a virtual KOL event featuring a leading #dermatology and immune-mediated skin disease expert to discuss the unmet need and current treatment landscape for individuals with mild to moderate #AtopicDermatitis. bit.ly/3Wg2OLz $ARQT

#NEWS: Today, we announced the submission of a supplemental New Drug Application for U.S. FDA review of our topical, steroid-free foam for the treatment of #scalp and body #psoriasis. Learn more: bit.ly/4bUcbX9

#NEWS: Today, we announced the nationwide availability of our once-daily treatment for #atopicdermatitis in adults and children ages 6+. Learn more: bit.ly/3yp9Vt6 #ClinicalDermatology #Launch #CompanyMilestone

Today, we announced the signing of a joint agreement with Kowa Pharmaceuticals America, Inc. to promote our once-daily, steroid-free cream and foam to primary care practitioners and pediatricians for all FDA approved indications. Learn more: bit.ly/3YmBcaa $ARQT

We’re sharing our gratitude to our colleagues near and far. Their commitment to meaningful innovation in #clinicaldermatology paved the way for our latest triumph: the launch of our once-daily treatment for #atopicdermatitis. Congratulations, all! #ThisisArcutUS #CompanyMilestone

Feeling the heat? 🌡 For those living with #psoriasis, warm weather can be challenging. In honor of #SummerSunSafetyMonth, take a moment to learn about taking care of skin in the summer: bit.ly/3Y31Ftg #SunSafety #UVProtection #PsoriasisActionMonth

#NEWS: Today, we are pleased to announce our strong #Q2 2024 financial results and provide an update on the growth of product portfolio sales. Read our release for full details: bit.ly/4cHBw7f $ARQT

Our approach to advancing meaningful innovation is powered by an understanding of what matters to those living with serious #skindiseases. David Berk, MD, FAAD, Vice President of R&D Strategy, shares more in the video below. #ClinicalDermatology #ThisIsArcutUS #Innovation #MedEd

It took nearly 20 years for Reena to share her #psoriasis journey. Now she uses her platform to encourage others living with psoriasis to find support and feel confident in their skin. Learn about psoriasis: bit.ly/4cYz5O8 #PatientStory #Dermatology #PsoriasisActionMonth

#NEWS: Today, we announced results from the study of our topical, steroid-free cream for #AtopicDermatitis in children aged 2-5. Learn about results from the INTEGUMENT-OLE long-term open-label study: bit.ly/4dYzrEF #ClinicalDermatology #Dermatology $ARQT

We hope stories like Samantha’s will encourage others living with #psoriasis to seek help and keep living life to the fullest. Learn about our approach to meaningful innovation: bit.ly/4czuNgd #PsoriasisActionMonth #PatientStory #Dermatology #ClinicalDermatology

We’re looking forward to attending the Morgan Stanley Global Healthcare Conference, where President and CEO, Frank Watanabe will host a fireside chat. Details below. #ClinicalDermatology $ARQT

#NEWS: Today, we announced the enrollment of the last subject in a Phase 1b #clinicaltrial evaluating our investigational treatment in #alopeciaareata. Learn more: bit.ly/4dQe6O2 #ClinicalDermatology #Dermatology $ARQT